Quest Diagnostics (DGX) Tops Q2 EPS by 30c; updates guidance
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $236.04 --0%
Financial Fact:
Cost of services: 1.16B
Today's EPS Names:
EGRX, MOVE, MDRX, More
Financial Fact:
Cost of services: 1.16B
Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q2 EPS of $3.12, $0.30 better than the analyst estimate of $2.82. Revenue for the quarter came in at $3.04 billion versus the consensus estimate of $2.97 billion.
GUIDANCE:
Quest Diagnostics sees FY2026 EPS of $11.05-$11.25, versus the consensus of $10.77. Quest Diagnostics sees FY2026 revenue of $11.95-12.05 billion, versus the consensus of $11.853 billion.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- RCM Technologies (RCMT) Tops Q2 EPS by 17c
- Kanen Wealth Management urges Zevia to explore a sale
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
